Clinical experience with daptomycin: bacteraemia and endocarditis

Donald P Levine1

  • 1Division of General Internal Medicine, Wayne State University, University Health Center, Detroit, MI 48201, USA. dlevine@med.wayne.edu

Insights

Daptomycin is an effective treatment for serious Staphylococcus aureus infections, including methicillin-resistant strains. This antibiotic shows comparable outcomes to vancomycin with reduced kidney toxicity.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Serious Staphylococcus aureus infections, particularly methicillin-resistant S. aureus (MRSA), pose a significant clinical challenge.
  • Vancomycin, the traditional treatment, exhibits slow bactericidal activity and increasing minimum inhibitory concentrations (MICs), driving the need for alternative therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of daptomycin as a treatment for Gram-positive bacterial infections.
  • To compare daptomycin's outcomes and nephrotoxicity against vancomycin or beta-lactam in combination with an aminoglycoside.

Main Methods:

  • Review of studies investigating daptomycin for various Gram-positive infections.
  • Analysis of a randomized controlled trial comparing daptomycin monotherapy with combination therapies.

Main Results:

  • Daptomycin demonstrated efficacy in treating bacteremic infections caused by staphylococci and vancomycin-resistant enterococci.
  • The randomized trial showed daptomycin achieved outcomes comparable to vancomycin/beta-lactam plus aminoglycoside.
  • Daptomycin exhibited significantly lower nephrotoxicity compared to the combination therapies.

Conclusions:

  • Daptomycin represents a promising alternative for treating serious Gram-positive infections, including MRSA.
  • Its favorable safety profile, particularly reduced nephrotoxicity, makes it a valuable therapeutic option.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...